SPY313.21+2.69 0.87%
DIA259.65+2.34 0.91%
IXIC10,252.06+97.44 0.96%

SVB Leerink Maintains Market Perform on Intersect ENT, Lowers Price Target to $14

SVB Leerink maintains Intersect ENT (NASDAQ:XENT) with a Market Perform and lowers the price target from $15 to $14.

Benzinga · -
SVB Leerink maintains Intersect ENT (NASDAQ: XENT) with a Market Perform and lowers the price target from $15 to $14.